You are here:
Additional information on budget policy and grants funding policies may be found at NIAMS Grant Funding Decisions
Funding Plan Fiscal Year 2015
November 3, 2015
NIAMS FY 2015 Operating Level: $521,665,000
The NIAMS is operating under the Consolidated and Further Continuing Appropriations Act of 2015. The funding plan below for research and training grants represents the most current information as of the date cited above; however, many factors occurring throughout the fiscal year can affect the operating policies, thus they are subject to change. For clarification it is always best to check with an appropriate Institute official.
Research Project Grants (RPGs)
Noncompeting continuation awards will be funded at the recommended level for FY 2015 that is reflected on the FY 2014 Notice of Grant Award.
- The payline for competing R01 applications will be paid through the percentile 12.0.
- The payline for competing R01 applications from new investigators will be paid through the percentile 17.0.
- The payline for competing R21 applications will be paid through the percentile 12.0.
- The payline for R15 applications will be paid through the percentile 6.0.
- The payline for the R03 application solicitation will be through the priority score 24.
- Based on case-by-case review of grant applications by program directors, reductions from direct costs recommended will be approximately 12 percent. No reductions will be taken on applications with direct costs of $100,000 or less.
- A pool of funds has been set aside for selective payment. Applications chosen for select pay are those that do not fall within the current percentile payline, but which are deemed to have particular relevance to the Institute's scientific and health priorities. Projects to be funded on this basis are recommended by Institute staff and/or Advisory Council members. Applicants may not apply for select pay consideration. Final decisions are made by the Director, NIAMS, following staff discussion.
- Rarely, NIAMS receives an application that is within the Institute’s payline, but is deemed to be of low program priority. In such instances, these cases are discussed in depth with members of the National Arthritis and Musculoskeletal and Skin Diseases Advisory Council before the Institute Director makes a final funding decision. An application can be considered low priority for many reasons, including (but not limited to) redundancy with other projects, concerns about the ultimate relevance of the proposed study’s results, or a lack of scientific premise.
- The payline for SBIR applications will be paid through the priority score 34.
- The payline for STTR applications will be paid through the priority score 29.
Research Career Awards
- The payline for K01/K08/K25 applications will be paid through the priority score 27.
- K23/24 applications will be paid through the priority score of 30.
- K99 applications will be paid through the priority score 28.
- The payline for research training fellowships (F31, F32, and F33) will be paid through a priority score of 22.
- The payline for research training fellowships (F30) will be paid through the percentile 5.0.
- The payline for institutional training applications (T32) will be paid through the priority score 20.